Exchange: NASDAQ·Updated 09:30 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

-$0.90

Reported EPS

-$0.71

Surprise

+21.27%

Estimated Rev

$26.03M

Reported Rev

$26.86M

Surprise

+3.21%

• Reported GAAP EPS of -$0.71 up 55.62% YoY • Reported revenue of $26.86M up 34.18% YoY • Biodesix expects total revenue of $108-114 million for full year 2026, with the midpoint representing approximately 25% growth over 2025, and maintains gross margin guidance of approximately 80% for 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.75
--
--
N/A
Q2 '26
-$0.90
-$0.71
21.27%
BEAT
Q1 '26
-$1.13
-$0.81
28.31%
BEAT
Q4 '25
-$0.86
-$0.49
43.04%
BEAT
Q3 '25
-$1.49
-$1.16
22.15%
BEAT

Advertisement|Remove ads.